Top section
Top section
UK follow-ons bring a secondary employee selldown and an increased primary capital raise
Helios's Moroccan health tech company T2S lists in Casablanca
Frédéric Despagne will also lead equity and derivatives sales across EMEA
More articles
More articles
More articles
-
HH&L Acquisition Corp has bagged $360m after increasing the size of its New York Stock Exchange IPO, in yet another sign that Asia-focused blank cheque companies are surging in popularity. -
Brookfield Asset Management has pulled off India’s third ever real estate investment trust IPO, raising Rp38bn ($521.7m) as strong demand covered the deal multiple times over.
-
JP Morgan has named Simone Haslinger and Jonas Troeber as the co-heads of its equity capital markets business in Australia and New Zealand.
-
European financial regulators have bowed to pressure from investment firms and their trade bodies, and look set to weaken the requirements of the Sustainable Finance Disclosure Regulation, a central part of the EU's Sustainable Finance Action Plan.
-
Huge demand for exposure to biotech companies among US equity investors is continuing to drive UK firms to list on the other side of the Atlantic through an IPO on the Nasdaq. On Thursday, Immunocore, a late-stage biotech firm focused on T-cell technology, priced an enlarged offering on the exchange and, on Friday, UK healthcare investor Syncona announced it was exploring a US IPO for one of its portfolio companies.
-
Hipgnosis Songs Fund, a London-listed investment trust focused on music royalties, has closed its latest share sale, raising £75m.
Sub-sections
shared comment list
